Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
19,74 USD | +4,28% | -4,91% | -15,46% |
Attività
Numero di dipendenti: 56
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Jonathan Young
FOU | Founder | 54 | 01/04/17 |
Timothy Rolph
FOU | Founder | 70 | 01/04/17 |
Andrew Cheng
CEO | Chief Executive Officer | 57 | 01/09/18 |
William White
DFI | Director of Finance/CFO | 51 | 01/04/19 |
Chief Tech/Sci/R&D Officer | - | 01/12/20 | |
Investor Relations Contact | - | - | |
Libette Luce
LAW | General Counsel | - | 01/05/22 |
Patrick Lamy
PRN | Corporate Officer/Principal | - | 01/01/23 |
Kitty Yale
PRN | Corporate Officer/Principal | 52 | 01/10/18 |
Arindam Bose
PRN | Corporate Officer/Principal | 71 | 01/01/19 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Seth Harrison
BRD | Director/Board Member | 63 | 01/01/17 |
Jane Henderson
BRD | Director/Board Member | 59 | 23/04/19 |
Mark Iwicki
CHM | Chairman | 57 | 01/11/18 |
Andrew Cheng
CEO | Chief Executive Officer | 57 | 01/09/18 |
Tomas Jan Heyman
BRD | Director/Board Member | 68 | 09/06/20 |
Jonathan Young
FOU | Founder | 54 | 01/04/17 |
Judy Chou
BRD | Director/Board Member | 58 | 12/07/21 |
Graham Walmsley
BRD | Director/Board Member | 37 | 01/06/18 |
Yuan Xu
BRD | Director/Board Member | 56 | 22/04/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 68 404 445 | 58 254 289 ( 85,16 %) | 0 | 85,16 % |
Coordinate società
Akero Therapeutics, Inc.
601 Gateway Boulevard Suite 350
94080-7006, South San Francisco
+650 487 6488
http://www.akerotx.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-15,46% | 1,37 Mrd | |
-2,31% | 103 Mrd | |
+0,56% | 95,28 Mrd | |
+1,69% | 22,15 Mrd | |
-17,37% | 21,02 Mrd | |
-9,30% | 18,15 Mrd | |
-41,01% | 16,73 Mrd | |
-14,85% | 16,05 Mrd | |
+3,21% | 13,68 Mrd | |
+33,54% | 12,17 Mrd |
- Borsa valori
- Azioni
- Azione AKRO
- Società Akero Therapeutics, Inc.